HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M J L' Ami Selected Research

Necrosis

7/2019Serum drug concentrations to optimize switching from adalimumab to etanercept in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M J L' Ami Research Topics

Disease

2Rheumatoid Arthritis
01/2023 - 07/2019
2Rheumatic Diseases (Rheumatism)
01/2023 - 07/2019
1Psoriatic Arthritis
01/2023
1Ankylosing Spondylitis
01/2023
1Necrosis
07/2019

Drug/Important Bio-Agent (IBA)

2Etanercept (Enbrel)FDA Link
01/2023 - 07/2019
1Tumor Necrosis Factor InhibitorsIBA
07/2019
1Adalimumab (Humira)FDA Link
07/2019